Uso de biomarcadores na sepse: muitas perguntas, poucas respostas
Authors:
Open Access
- 1 March 2013
- journal article
- Published by GN1 Sistemas e Publicacoes Ltd. in Revista Brasileira de Terapia Intensiva
- Vol. 25 (1) , 1-2
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Dosagens séricas de proteína C-reativa na fase inicial da sepse abdominal e pulmonarRevista Brasileira de Terapia Intensiva, 2013
- Novel biomarkers in severe community-acquired pneumonia.2011
- Open Versus Laparoscopic Treatment for Pan-Peritonitis Secondary to Perforated Appendicitis in Children: A Prospective AnalysisJournal of Laparoendoscopic & Advanced Surgical Techniques, 2010
- Biomarkers as end points in clinical trials of severe sepsis: A garden of forking paths*Critical Care Medicine, 2010
- Sepsis biomarkers: a reviewCritical Care, 2010
- Multicenter, randomized, controlled trials evaluating mortality in intensive care: Doomed to fail?Critical Care Medicine, 2008
- Serum markers in community-acquired pneumonia and ventilator-associated pneumoniaCurrent Opinion in Infectious Diseases, 2008
- Measures, markers, and mediators: Toward a staging system for clinical sepsis. A Report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25–26, 2000Critical Care Medicine, 2003
- Such stuff as dreams are made on: mediator-directed therapy in sepsisNature Reviews Drug Discovery, 2003
- C-reactive protein: a valuable marker of sepsisIntensive Care Medicine, 2002